Novo Nordisk A/S 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-22 08:00 am Sale | 2026-05-29 | 13G | INNATE PHARMA S A SPONSORED AD IPHA | Novo Nordisk A/S | 0 0.000% | -4,718,727 (Position Closed) | Filing |
| 2026-04-10 08:30 am Sale | 2026-03-31 | 13G | INNATE PHARMA S A SPONSORED AD IPHA | Novo Nordisk A/S | 4,718,727 5.030% | -2,615,051 (-35.66%) | Filing |
| 2026-03-04 4:45 pm Sale | 2025-12-31 | 13G | INNATE PHARMA S A SPONSORED AD IPHA | Novo Nordisk A/S | 7,333,778 7.820% | -1,561,871 (-17.56%) | Filing |
| 2025-10-21 08:00 am Sale | 2025-07-14 | 13G | INNATE PHARMA S A SPONSORED AD IPHA | Novo Nordisk A/S | 8,895,649 9.650% | -921,897 (-9.39%) | Filing |